HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Liang Wang Selected Research

2-(1-hydroxypentyl)-benzoate

2/2018Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs.
4/2017Toxicokinetics and toxicity of potassium 2-(1-hydroxypentyl)-benzoate in beagle dogs.
7/2014Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice.
6/20062-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Liang Wang Research Topics

Disease

13Pain (Aches)
01/2022 - 07/2014
11Neoplasms (Cancer)
01/2022 - 03/2008
10Alzheimer Disease (Alzheimer's Disease)
12/2018 - 03/2002
9Hypersensitivity (Allergy)
01/2021 - 07/2014
8Brain Ischemia (Cerebral Ischemia)
09/2015 - 10/2002
7Ischemia
09/2015 - 06/2006
5Neuralgia (Stump Neuralgia)
01/2020 - 12/2014
4Inflammation (Inflammations)
11/2022 - 01/2016
4Neuroinflammatory Diseases
08/2022 - 10/2016
4Cognitive Dysfunction
08/2022 - 01/2005
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 03/2008
4Neuroblastoma
01/2018 - 01/2014
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 07/2007
4Hypoxia (Hypoxemia)
01/2017 - 08/2010
4Hyperalgesia
01/2017 - 03/2016
4Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2016 - 10/2010
4Stroke (Strokes)
01/2016 - 06/2006
3Ischemic Stroke
02/2018 - 07/2014
3Melanoma (Melanoma, Malignant)
07/2017 - 01/2012
3Parkinson Disease (Parkinson's Disease)
06/2017 - 05/2015
3Neurodegenerative Diseases (Neurodegenerative Disease)
06/2017 - 01/2016
3Myocardial Infarction
12/2015 - 04/2011
3Infarction (Infarctions)
07/2012 - 06/2006
2Traumatic Brain Injuries (Traumatic Brain Injury)
11/2022 - 01/2022
2Brain Edema (Cerebral Edema)
01/2022 - 10/2016
2Neoplasm Metastasis (Metastasis)
12/2020 - 07/2014
2Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 01/2014
2Chronic Pain
01/2017 - 01/2017
2Brain Injuries (Brain Injury)
10/2016 - 12/2014
2Infections
06/2015 - 06/2014
2Hepatocellular Carcinoma (Hepatoma)
06/2015 - 01/2012
2Memory Disorders (Memory Loss)
07/2014 - 01/2005
2Colonic Neoplasms (Colon Cancer)
07/2014 - 06/2012
2Reperfusion Injury
07/2012 - 08/2010
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2006 - 02/2005
1Weight Loss (Weight Reduction)
12/2021
1Temporal Lobe Epilepsy
09/2019
1Absence Epilepsy (Childhood Absence Epilepsy)
09/2019

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2006
10Bee Venoms (Bee Venom)IBA
01/2021 - 07/2014
7Neuroprotective AgentsIBA
01/2022 - 01/2014
5Pharmaceutical PreparationsIBA
01/2020 - 06/2006
4Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2012
4Small Interfering RNA (siRNA)IBA
01/2022 - 06/2014
4Analgesics (Analgesic Drugs)IBA
01/2021 - 03/2016
4Glutamic Acid (Glutamate)FDA Link
09/2019 - 05/2006
4PotassiumIBA
02/2018 - 01/2005
42-(1-hydroxypentyl)-benzoateIBA
02/2018 - 06/2006
43-n-butylphthalide (butylphthalide)IBA
02/2018 - 08/2003
3AntioxidantsIBA
01/2022 - 12/2014
3Freund's AdjuvantIBA
01/2022 - 01/2017
3Amyloid (Amyloid Fibrils)IBA
01/2018 - 01/2014
3Biological ProductsIBA
11/2012 - 10/2011
3Caspase 3 (Caspase-3)IBA
07/2012 - 08/2003
3Protein Isoforms (Isoforms)IBA
06/2012 - 10/2002
3Potassium Channels (Potassium Channel)IBA
11/2006 - 03/2002
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2008
2Guanosine Triphosphate (GTP)IBA
01/2021 - 03/2016
2Therapeutic UsesIBA
09/2019 - 05/2006
2ProdrugsIBA
02/2018 - 04/2017
2Cholinergic Agents (Cholinergics)IBA
01/2018 - 01/2005
2squamosamideIBA
06/2017 - 05/2015
2plerixaforFDA Link
01/2017 - 01/2017
2mocetinostatIBA
01/2017 - 10/2015
2Chemokine CXCL12IBA
01/2017 - 01/2017
2Gabapentin (Neurontin)FDA LinkGeneric
01/2017 - 12/2014
2p38 Mitogen-Activated Protein KinasesIBA
03/2016 - 08/2010
2ElementsIBA
01/2016 - 12/2014
2Interleukin-6 (Interleukin 6)IBA
06/2015 - 01/2012
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2014 - 11/2012
2Antineoplastic Agents (Antineoplastics)IBA
11/2012 - 10/2011
2Creatine Kinase (Creatine Phosphokinase)IBA
07/2012 - 01/2010
2Messenger RNA (mRNA)IBA
02/2005 - 01/2005
2Galantamine (Galanthamine)FDA LinkGeneric
11/2004 - 01/2003
2Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2004 - 01/2003
1Protein Kinases (Protein Kinase)IBA
08/2022
1PhytochemicalsIBA
08/2022
1Adenosine (Adenocard)FDA LinkGeneric
08/2022
1rhodiolosideIBA
08/2022
1Cell-Free Nucleic AcidsIBA
01/2022
1TRPV1 receptorIBA
01/2022
1oridoninIBA
01/2022
1K-18 conjugate (K18)IBA
12/2021
1InterferonsIBA
12/2021
1Purinergic P2X3 ReceptorsIBA
01/2021
1tetrahydropalmatineIBA
01/2021
1neurabinIBA
01/2021
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
01/2021
1halofuginoneIBA
12/2020
1Fluorouracil (Carac)FDA LinkGeneric
12/2020
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2020
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
01/2020
1LactamsIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1STA 9090IBA
09/2019

Therapy/Procedure

4Therapeutics
01/2018 - 01/2003
2Injections
01/2020 - 01/2017
1Intravenous Administration
11/2022
1Orthopedic Procedures
08/2022
1Drug Therapy (Chemotherapy)
12/2020